title: Reproductive experience reduces striatal dopaminergic responses in freely moving female rats.
abstract: Reproductive experience influences basal and pregnancy profiles of circulating prolactin levels in women and female rats, respectively. Endocrine responses to dopaminergic antagonists are modified by reproductive experience as well. Striatal extracellular dopamine metabolites were measured in vivo by HPLC-ED in perfusates obtained by microdialysis in non-anaesthetized, freely moving, intact and ovariectomized, nulliparous and primiparous rats. Data were collected for at least 7 h. This period always included the light-dark shift at 18:00 h. In a second experiment, microdialysis was performed in ovariectomized nulliparous and primiparous rats treated with haloperidol (1.0 mg/kg s.c.). During the 1 h before and after the onset of the light-dark shift, HVA concentrations in the perfusates increased in nulliparous compared with primiparous rats. The haloperidol-induced increase in DOPAC and HVA was less intense in primiparous rats than that in nulliparous ovariectomized rats. These data revealed a different pattern of striatal dopaminergic anticipation and response to the shift in the light-dark cycle in nulliparous as compared with primiparous intact females. In addition, a distinct striatal dopaminergic response to haloperidol was observed in primiparous as compared to nulliparous ovariectomized rats. The results suggest that reproductive experience can modulate the activity of dopaminergic terminals in the striatum.
authors.affiliation: Department of Pathology, Faculty of Veterinary Medicine, Cidade Universitária, Sao Paulo, SP, Brazil.
authors.forename: E E
authors.initials: EE
authors.lastname: Hucke
authors.forename: P E
authors.initials: PE
authors.lastname: Cruz-Casallas
authors.forename: J C
authors.initials: JC
authors.lastname: Florio
authors.forename: L F
authors.initials: LF
authors.lastname: Felicio
mesh_terms: D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects / Q000502:physiology; D002909:Chronobiology Phenomena / Q000502:physiology; D004298:Dopamine / Q000378:metabolism*; D018492:Dopamine Antagonists / Q000494:pharmacology; D005260:Female; D006220:Haloperidol / Q000494:pharmacology; D006719:Homovanillic Acid / Q000378:metabolism; D008124:Locomotion; D017551:Microdialysis; D017072:Neostriatum / Q000737:chemistry / Q000378:metabolism*; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D018492:Dopamine Antagonists; D015102:3,4-Dihydroxyphenylacetic Acid; D006220:Haloperidol; D004298:Dopamine; D006719:Homovanillic Acid